Table 3.

Hazard ratio and 95%CI for proportional hazard models assessing the effect of variables associated with survival (univariate analysis)

	Coefficient (SE)	Hazard ratio (95%CI)	p
BMI < =21	0.51 (0.25)	1.67 (1.03–2.73)	0.037
NRI < =97.5	0.54 (0.25)	1.71 (1.04–2.81)	0.033
WHO Score*	− 0.47 (0.23)	0.63 (0.4–0.99)	0.044
Sarcopenia****	0.96 (0.24)	2.61 (1.61–4.24)	< 0.001
Weight loss<=5%	−0.35 (0.24)	0.71 (0.44–1.13)	0.142
Weight loss<=10%	−0.13 (0.26)	0.88 (0.53–1.45)	0.604
Albumin levels<=35(g/l)	−0.23 (0.31)	0.79 (0.43–1.45)	0.449
BMI < =18	0.61 (0.33)	1.84 (0.96–3.53)	0.061
Masculine Sex	0.53 (0.34)	1.7 (0.87–3.3)	0.116
Age < =65	−0.3 (0.23)	0.74 (0.47–1.16)	0.186
Histology ***	0.32 (0.29)	1.38 (0.77–2.47)	0.277
SUV max<=12.3	−0.33 (0.23)	0.72 (0.46–1.13)	0.154
TVol40 < =9.9	−0.44 (0.28)	0.64 (0.37–1.12)	0.116
Muscular Mean Density < =41 (for BMI < 25)	0.02 (0.43)	1.02 (0.43–2.41)	0.957
Muscular Mean Density < =33 (for BMI > 25)	1.11 (0.74)	3.02 (0.71–12.82)	0.116
Metastasis **	−0.33 (0.33)	0.72 (0.38–1.37)	0.315

*Versus patients with WHO score > 0. ** Versus patient without metastasis. ***SCC versus OA. **** Defined as SMI < 38.3 cm²/m² for women and < 52.4 cm²/m² for men